Catalyst Pharmaceuticals, Inc.

Ownership Transactions Reported by 15 Insiders

Symbol
CPRX on Nasdaq
Industry
Pharmaceutical Preparations
Location
355 Alhambra Circle, Suite 801, Coral Gables, FL

Insiders trading volume in the past year

Catalyst Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Patrick J. Mcenany Director, Chairman of Board of Directors $92.9M Aug 22, 2024
Steve Miller Chief Op. & Scientific Officer $15.7M -$3.62M -18.7% Aug 20, 2024
David S. Tierney Director $7.27M -$1.36M -15.8% Aug 21, 2024
Richard J. Daly President and CEO, Director $5.75M -$277K -4.59% Jun 4, 2024
Brian Elsbernd Chief Compliance/Legal Officer $3.19M -$411K -11.4% Mar 27, 2024
Gary Ingenito Chief Med. & Reg. Officer $2.2M -$3.8M -63.3% Aug 9, 2024
Alicia Grande VP, Treasurer and CFO $1.4M -$1.4M -49.9% Dec 27, 2023
Jeffrey Del Chief Commercial Officer $1.17M -$785K -40.2% Aug 9, 2024
Tamar Thompson Director $1.06M Dec 8, 2023
Charles B. O'Keeffe Director $1.03M Feb 15, 2024
Donald A. Denkhaus Director $709K Feb 15, 2024
Preethi Sundaram Chief Strategy Officer $655K Feb 15, 2024
Philip H. Coelho Director $232K May 4, 2023
Molly Harper Director $142K -$288K -67% Jun 3, 2024
Michael W. Kalb Executive Vice President & CFO Jan 1, 2024

Recent Insider Transactions by Companies or Individuals for Catalyst Pharmaceuticals, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.